Novo Nordisk (NVO) plans to launch its blockbuster weight-loss drug Wegovy in vial format. The move targets customers who have shifted to rival Eli Lilly & Co. (LLY).
This packaging change follows Eli Lilly’s lead in offering similar options for obesity treatments. Novo Nordisk currently distributes Wegovy exclusively through plastic injector pens.
The update aims to broaden accessibility and boost competitiveness in the growing market for weight management drugs.
WASHINGTON, D.C. — Prime Minister Mark Carney's recent trade agreement with China sparks concerns in Washington and beyond, raising questions…
Bitget Wallet has introduced a novel rewards program for its cardholders, replacing traditional cash rebates with a selection of digital…
A man who subjected a young puppy to extreme cruelty, resulting in multiple injuries that forced veterinarians to euthanize the…
Customers of major banks like Nationwide can secure a £200 payment by switching their current account to Santander. This incentive…
